Literature DB >> 25750765

Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature.

Jessica L Petrick1, Nan Li1, Kathleen M McClain1, Susan E Steck2, Marilie D Gammon3.   

Abstract

Esophageal adenocarcinoma (EA) incidence is among the most rapidly increasing of any cancer type in the U.S., and prognosis is poor. Prevalence of the potential precursor lesion, Barrett's esophagus (BE), is also increasing. Candidates for safe and effective risk reduction strategies are needed, potentially including dietary components. In this qualitative review, we summarize recently published epidemiologic studies, in context of earlier work, on dietary intake and BE-EA outcomes. Potential cohort study/intervention trial candidates which could be increased to reduce BE-EA development include intake of: (1) fruits and vegetables; vegetables; fruit (EA only); (2) β-carotene and vitamins C and E; (3) folate (EA only); and (4) total fiber (EA only). Also, (5) red and processed meat intake could be targeted for dietary reduction/omission to reduce EA development. Few dietary constituents have been evaluated among EA patients to examine associations with mortality, thus interventions conducted among EA patients are premature.

Entities:  

Keywords:  Barrett's esophagus; dietary intake; epidemiology; esophageal adenocarcinoma; folate; fruits; nutrition; red meat; survivorship; total fiber; vegetables; vitamin C; vitamin E; β-carotene

Year:  2015        PMID: 25750765      PMCID: PMC4349493          DOI: 10.1007/s13668-014-0108-0

Source DB:  PubMed          Journal:  Curr Nutr Rep        ISSN: 2161-3311


  84 in total

1.  Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus.

Authors:  L Jiao; J R Kramer; L Chen; M Rugge; P Parente; G Verstovsek; A Alsarraj; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2013-08-19       Impact factor: 8.171

2.  Diet and risk of esophageal cancer by histologic type in a low-risk population.

Authors:  A Tzonou; L Lipworth; A Garidou; L B Signorello; P Lagiou; C Hsieh; D Trichopoulos
Journal:  Int J Cancer       Date:  1996-11-04       Impact factor: 7.396

3.  Flavopiridol reduces malignant transformation of the esophageal mucosa in p27 knockout mice.

Authors:  Mirna Lechpammer; Xiangjun Xu; F Henry Ellis; Nandita Bhattacharaya; Geoffrey I Shapiro; Massimo Loda
Journal:  Oncogene       Date:  2005-03-03       Impact factor: 9.867

4.  Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.

Authors:  James C Barton; Ronald T Acton; Fitzroy W Dawkins; Paul C Adams; Laura Lovato; Cathie Leiendecker-Foster; Christine E McLaren; David M Reboussin; Mark R Speechley; Victor R Gordeuk; Gordon D McLaren; Phyliss Sholinsky; Emily L Harris
Journal:  Genet Test       Date:  2005

5.  Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study.

Authors:  A P Keszei; L J Schouten; R A Goldbohm; P A van den Brandt
Journal:  Ann Oncol       Date:  2012-02-20       Impact factor: 32.976

6.  Risk factors in the development of esophageal adenocarcinoma.

Authors:  Heiko Pohl; Katharina Wrobel; Christian Bojarski; Winfried Voderholzer; Amnon Sonnenberg; Thomas Rösch; Daniel C Baumgart
Journal:  Am J Gastroenterol       Date:  2012-12-18       Impact factor: 10.864

7.  Anti-inflammatory effects of plant-based foods and of their constituents.

Authors:  Bernhard Watzl
Journal:  Int J Vitam Nutr Res       Date:  2008-12       Impact factor: 1.784

8.  Dietary flavonoid intake and esophageal cancer risk in the European prospective investigation into cancer and nutrition cohort.

Authors:  Esther Vermeulen; Raul Zamora-Ros; Eric J Duell; Leila Luján-Barroso; Heiner Boeing; Krasimira Aleksandrova; H Bas Bueno-de-Mesquita; Augustin Scalbert; Isabelle Romieu; Veronika Fedirko; Marina Touillaud; Guy Fagherazzi; Florence Perquier; Esther Molina-Montes; Maria-Dolores Chirlaque; Marcial Vicente Argüelles; Pilar Amiano; Aurelio Barricarte; Valeria Pala; Amalia Mattiello; Calogero Saieva; Rosario Tumino; Fulvio Ricceri; Antonia Trichopoulou; Effie Vasilopoulou; Gianna Ziara; Francesca L Crowe; Kay-Thee Khaw; Nicholas J Wareham; Annekatrin Lukanova; Verena A Grote; Anne Tjønneland; Jytte Halkjær; Lea Bredsdorff; Kim Overvad; Peter D Siersema; Petra H M Peeters; Anne M May; Elisabete Weiderpass; Guri Skeie; Anette Hjartåker; Rikard Landberg; Ingegerd Johansson; Emily Sonestedt; Ulrika Ericson; Elio Riboli; Carlos A González
Journal:  Am J Epidemiol       Date:  2013-05-06       Impact factor: 4.897

9.  Intakes of folate, methionine, vitamin B6, and vitamin B12 with risk of esophageal and gastric cancer in a large cohort study.

Authors:  Q Xiao; N D Freedman; J Ren; A R Hollenbeck; C C Abnet; Y Park
Journal:  Br J Cancer       Date:  2014-01-30       Impact factor: 7.640

10.  Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis.

Authors:  Stephanie A Navarro Silvera; Susan T Mayne; Marilie D Gammon; Thomas L Vaughan; Wong-Ho Chow; Joel A Dubin; Robert Dubrow; Janet L Stanford; A Brian West; Heidrun Rotterdam; William J Blot; Harvey A Risch
Journal:  Ann Epidemiol       Date:  2013-10-18       Impact factor: 6.996

View more
  2 in total

1.  A pooled analysis of dietary sugar/carbohydrate intake and esophageal and gastric cardia adenocarcinoma incidence and survival in the USA.

Authors:  Nan Li; Jessica L Petrick; Susan E Steck; Patrick T Bradshaw; Kathleen M McClain; Nicole M Niehoff; Lawrence S Engel; Nicholas J Shaheen; Harvey A Risch; Thomas L Vaughan; Anna H Wu; Marilie D Gammon
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

2.  Association between selenium levels and oesophageal adenocarcinoma risk: evidence from a meta-analysis.

Authors:  Bin Hong; Lihong Huang; Ning Mao; Tao Xiong; Chao Li; Liangbo Hu; Ying Du
Journal:  Biosci Rep       Date:  2016-07-07       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.